Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schollmeyer

Showing results (51-60 of 731) with videos related to

Pageof 74
Sort By:
IEEE Transactions on Visualization and Computer Graphics|September 11, 2015
Direct Isosurface Ray Casting of NURBS-Based Isogeometric AnalysisAndre Schollmeyer, Bernd Froehlich
Clinical Nephrology|January 1, 1988
The immune status of the uremic patient: hemodialysis vs CAPDP Schollmeyer, F Bozkurt
APMIS. Supplementum|January 1, 1990
Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseasesP Schollmeyer, W Grotz
Iucrdata|November 7, 2022
<i>rac</i>-11-Selena-12,13-di-aza-bicyclo-[10.3.0]penta-deca-10a(13a),12-dien-1-olHeiner Detert, Dieter Schollmeyer
Iucrdata|February 16, 2023
(<i>Z</i>)-4,5-Di-bromo-3,3,6,6-tetra-methyl-2,3,6,7-tetra-hydro-thiepine-1,1-dioneDieter Schollmeyer, Heiner Detert
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
Decachloro-hexa-1,5-dieneDieter Schollmeyer, Heiner Detert
British Journal of Pharmacology|July 1, 1989
Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidneyL C Rump, P Schollmeyer
Agents and Actions|October 1, 1973
Biochemical effects of adamatanamines, a new class of drugs with antiparkinson activityW Wesemann, J D Schollmeyer
Journal of Cosmetic Science|June 8, 2002
Applications of cyclodextrins in cosmetic products: A reviewHans-Jürgen Buschmann, Eckhard Schollmeyer
Deutsche Medizinische Wochenschrift (1946)|September 1, 1989
[Pathogenesis, diagnosis and therapy of type IV renal tubular acidosis]K W Dreyling, P Schollmeyer
Pageof 74

Showing results (51-60 of 731) with videos related to

Sort By:
Pageof 74
IEEE Transactions on Visualization and Computer Graphics|September 11, 2015
Direct Isosurface Ray Casting of NURBS-Based Isogeometric AnalysisAndre Schollmeyer, Bernd Froehlich
Clinical Nephrology|January 1, 1988
The immune status of the uremic patient: hemodialysis vs CAPDP Schollmeyer, F Bozkurt
APMIS. Supplementum|January 1, 1990
Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseasesP Schollmeyer, W Grotz
Iucrdata|November 7, 2022
<i>rac</i>-11-Selena-12,13-di-aza-bicyclo-[10.3.0]penta-deca-10a(13a),12-dien-1-olHeiner Detert, Dieter Schollmeyer
Iucrdata|February 16, 2023
(<i>Z</i>)-4,5-Di-bromo-3,3,6,6-tetra-methyl-2,3,6,7-tetra-hydro-thiepine-1,1-dioneDieter Schollmeyer, Heiner Detert
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
Decachloro-hexa-1,5-dieneDieter Schollmeyer, Heiner Detert
British Journal of Pharmacology|July 1, 1989
Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidneyL C Rump, P Schollmeyer
Agents and Actions|October 1, 1973
Biochemical effects of adamatanamines, a new class of drugs with antiparkinson activityW Wesemann, J D Schollmeyer
Journal of Cosmetic Science|June 8, 2002
Applications of cyclodextrins in cosmetic products: A reviewHans-Jürgen Buschmann, Eckhard Schollmeyer
Deutsche Medizinische Wochenschrift (1946)|September 1, 1989
[Pathogenesis, diagnosis and therapy of type IV renal tubular acidosis]K W Dreyling, P Schollmeyer
Pageof 74